entertainment -WSS

entertainment

author：leisure time 2025-09-30 08:49:50 - browse：293

If you ask a chatbot how to cause a pandemic, it will suggest the 1918 influenza virus, according to researcher Kevin Esvelt. It will even tell you where to find the gene sequences online and where to purchase the genetic components.

Esvelt is a biologist and MIT professor whose work has included altering the genes of mice to prevent the spread of Lyme disease. In a recent First Opinion essay, he wrote about how easy and inexpensive it has become to order genetic components that could be used to create harmful pathogens or toxins and how the biotech industry and government agencies must strengthen safety precautions to prevent this.

Esvelt sat down with host Pat Skerrett to chat about the amazing things genetic technology can accomplish when used correctly, as well as the dangers of such technology in the hands of someone with bad intentions.

“We’re trying to do biotech to accomplish amazing things and heal people,” Esvelt said. “You don’t want to think about the same tools being misused and, to most scientists, this doesn’t come naturally.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

Newsletters

Sign up for First Opinion Podcast

Weekly alerts when a new episode drops from STAT’s First Opinion podcast

Please enter a valid email address. Privacy Policy

Previous article： Drug repurposing or repositioning? The language matters
Next article： Why the drug industry's warnings on the IRA's impact fall short

WSS

Virtual care provider acquires bankrupt Pear's prescription apps

David Ricks of Eli Lilly: best biopharma CEO of 2023

Albert Bourla of Pfizer: worst biopharma CEO of 2023

HCA sued by state AG for quality issues at Mission Health

What happened to the House vote on health price transparency?

SEC charges former device maker CEO with $41 million fraud

entertainment

entertainment

Sign up for First Opinion Podcast

knowledge

Supreme Court strikes down use of affirmative action

How to keep neuroscience’s past racism from being its future

Apple is now the first public company to be valued at $3 trillion

PBMs drew scrutiny in House hearing — and so did pharma

Cancer drug shortages should be causing more outrage

House panel takes first step toward fixing drug shortages

How to save PrEP access — and even expand it

Akili changes sales model for its ADHD video game treatment

The cancer drug shortage isn’t new — and neither are the solutions

Covid’s new normal has set in amid another rise in cases

focus

Grad students accuse University of California of wage theft

Grad students accuse University of California of wage theft

Albert Bourla of Pfizer: worst biopharma CEO of 2023

Prime Medicine, Myeloid Therapeutics clash over genome

Editas, Vertex strike deal on CRISPR

Bristol Myers buys into radiopharmaceuticals with RayzeBio

entertainment

focus

explore

entertainment